{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-095085","form_type":"8-K","ticker":"SLDB","cik":"0001707502","company_name":"Solid Biosciences Inc.","filed_at":"2022-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.926785+00:00","generated_at":"2026-06-26T09:50:53.930278+00:00","sec_items":["5.05"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Solid Biosciences board adopts new Code of Business Conduct and Ethics","bullets":["Board approved new Code of Business Conduct and Ethics on March 30, 2022.","New code replaces prior code in its entirety; no explicit or implicit waivers granted.","Code applies to all employees, officers, directors of Solid Biosciences and its subsidiaries.","Full text posted at https://investors.solidbio.com/governance/governance-documents."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-095085","json":"https://secwatch.observer/filing/0001193125-22-095085.json","markdown":"https://secwatch.observer/filing/0001193125-22-095085.md","text":"https://secwatch.observer/filing/0001193125-22-095085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1707502/000119312522095085/0001193125-22-095085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1707502/000119312522095085/d272083d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:50:53.930278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}